June 3, 2020
The Texas Drug Utilization Review Board met recently and made recommendations about drugs to be included on the Medicaid preferred drug list.
May 4, 2020
A quarterly update of what clinical prior authorizations each MCO uses and how those prior authorizations relate to the clinical prior authorizations used for traditional Medicaid claim processing.
April 23, 2020
April 17, 2020
The Vendor Drug Program will revise the clinical prior authorization criteria for protein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on July 7.
April 15, 2020
The quarterly crosswalk identifies relationships between National Drug Codes and Medicaid payable Healthcare Common Procedure Coding System codes.
April 10, 2020
April 3, 2020
March 20, 2020
The quarterly use and expenditure pattern reports provide prescription drug use and expenditure information for the most prescribed individual drugs and therapeutic drug classes.